Juniper Pharma (JNP) Tops Q4 EPS by 7c, Miss on Revenues

Note: EPS may not be comparable

Juniper Pharma (NASDAQ: JNP) reported Q4 EPS of ($0.04), $0.07 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $11.4 million versus the consensus estimate of $16 million.

For earnings history and earnings-related data on Juniper Pharma (JNP) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c